Carcinoma: all 6,718 studies
Page 9 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- BGT007 Cell Treatment of Nasopharyngeal CarcinomaRecruitingNCT05616468Early Phase 1
- Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular CarcinomaRecruitingNCT05616390Phase 2
- Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular CarcinomaRecruitingNCT05613478Phase 3
- Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance TechnologiesRecruitingNCT05611515
- Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular CarcinomaNot yet recruitingNCT05609695
- Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCCRecruitingNCT05608213Phase 3
- Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCCRecruitingNCT05608200Phase 3
- Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III StudyNot yet recruitingNCT05602974Not applicable
- Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer PatientsRecruitingNCT05596890Phase 2
- Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCCRecruitingNCT05596630Not applicable
- Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)RecruitingNCT05594927Phase 3
- AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell CarcinomaNot yet recruitingNCT05594914Phase 2
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/2
- Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall InvasionRecruitingNCT05589207
- Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal CancersNot yet recruitingNCT05582590Phase 1
- Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)RecruitingNCT05582265Phase 3
- Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular CarcinomaRecruitingNCT05573282
- Lenvatinib Therapy in HCC Patients After LDLTRecruitingNCT05572528
- Pembrolizumab Plus Radiotherapy for Advanced Renal CancerRecruitingNCT05567588Phase 2
- Cabozantinib and Dostarlimab in Recurrent Gynecologic CarcinosarcomaRecruitingNCT05559879Phase 1/2
- A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)RecruitingNCT05548621
- De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNARecruitingNCT05541016Phase 2
- Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous CarcinomaRecruitingNCT05537844
- Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCCRecruitingNCT05533892Phase 1
- Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaRecruitingNCT05527470Phase 3
- Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International GuidelinesNot yet recruitingNCT05519956Phase 3
- Sintilimab Combined With Lenvatinib Versus HAIC for Perioperative Treatment of Resectable Primary Hepatocellular CarcinomaRecruitingNCT05519410Phase 2
- tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)RecruitingNCT05517135
- Radiotherapy Combined With Endostatin and Capecitabine for NPCRecruitingNCT05514275Phase 2
- Phase II Dutasteride in Combination With CAB vs CAB in SDCRecruitingNCT05513365Phase 2
- Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003）RecruitingNCT05512520Phase 2
- Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05508347Phase 2
- Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCCRecruitingNCT05507411Phase 2
- Relevance of Sarcopenia in Advanced Liver DiseaseRecruitingNCT05502198
- AMT-151 in Patients With Selected Advanced Solid TumoursRecruitingNCT05498597Phase 1
- EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung CancerNot yet recruitingNCT05498389Phase 1/2
- Disitamab Vedotin Combined With Tislelizumab for Her2 Overexpressing High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely ResectableRecruitingNCT05495724Phase 2
- Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT05495152Phase 3
- A Phase II Study of CRT Combined With QL1706 in ESCC PatientsRecruitingNCT05490719Phase 2
- Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell CarcinomaRecruitingNCT05490485Phase 2
- A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative ResectionRecruitingNCT05489289Phase 3
- Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCCRecruitingNCT05484908Not applicable
- Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line TreatmentNot yet recruitingNCT05484375Phase 2
- HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority StudyRecruitingNCT05476432Phase 3
- A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected MalignanciesRecruitingNCT05473156Phase 1/2
- Antiviral Therapy for Patients With Liver Cancer After SurgeryRecruitingNCT05466565
- Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration StudyRecruitingNCT05463757
- Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological MalignanciesRecruitingNCT05457595Not applicable
- Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR)Not yet recruitingNCT05456074
- Detection of Oral and Throat Cancers Using OralViome Cancer Testing SystemRecruitingNCT05451303
- Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell CarcinomaRecruitingNCT05449483Phase 2
- Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal CarcinomaRecruitingNCT05448885Phase 2
- Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic TherapiesEnrolling by invitationNCT05448222
- Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma ScreeningRecruitingNCT05447169
- Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular CarcinomaRecruitingNCT05444478Not applicable
- Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT05444088Phase 1/2
- Durvalumab and Tremelimumab in Resectable HCCRecruitingNCT05440864Phase 2
- Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ CarcinomaRecruitingNCT05439993Phase 1/2
- Re-optimization Based Online Adaptive Radiotherapy of Anal CancerRecruitingNCT05438836
- Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCCRecruitingNCT05437380Not applicable
- A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal CarcinomaNot yet recruitingNCT05432219Not applicable
- Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT05431764Phase 2
- Validation of SMS Protocol for HCC Screening in High-risk PatientsEnrolling by invitationNCT05429190
- Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant TherapyNot yet recruitingNCT05420480Not applicable
- Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter StudyNot yet recruitingNCT05417139Phase 2
- Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasRecruitingNCT05415098Phase 1
- A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular CarcinomaRecruitingNCT05409482
- the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular CarcinomaRecruitingNCT05408221Phase 2/3
- A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative ResectionRecruitingNCT05407519Phase 2
- SOTO: Treatment Sensitivity of Organoids to Predict Treatment OutcomeRecruitingNCT05400239
- Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.RecruitingNCT05397769Phase 2
- Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer PatientsEnrolling by invitationNCT05396118Phase 2
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal CarcinomatosisRecruitingNCT05395910Phase 1
- Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma PatientsRecruitingNCT05374252Phase 3
- An Intervention for Female Breast CANcer: Acceptance and Commitment Therapy (I-CAN-ACT) for Depression and Physical PainRecruitingNCT05374161Not applicable
- Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal MetastasesRecruitingNCT05371223Phase 2
- HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons in HNSCCRecruitingNCT05364411Not applicable
- A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerRecruitingNCT05361174Phase 1/2
- A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular CarcinomaRecruitingNCT05359939Not applicable
- NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical ResectionRecruitingNCT05352646Phase 1
- Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal CarcinomaRecruitingNCT05352321Not applicable
- Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPCRecruitingNCT05350891Phase 2
- Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal CarcinomaRecruitingNCT05342792Phase 3
- An Observational Study of Clinical Treatments for Patients With Oropharyngeal CarcinomaRecruitingNCT05341479
- PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT05341193Phase 1/2
- L19IL2/L19TNF in Skin Cancer PatientsRecruitingNCT05329792Phase 2
- National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)RecruitingNCT05326620
- Study Of B7H3 CAR-T Cells in Treating Advanced Liver CancerRecruitingNCT05323201Phase 1/2
- Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer PatientsRecruitingNCT05319886
- A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC ClassificationRecruitingNCT05313282Phase 3
- A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial CarcinomaRecruitingNCT05302284Phase 3
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept StudyNot yet recruitingNCT05293158Not applicable
- A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)RecruitingNCT05286619Phase 2
- Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.Not yet recruitingNCT05286320Phase 1/2
- Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor TherapyRecruitingNCT05283226Phase 2
- Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)RecruitingNCT05281003Phase 2
- Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial CarcinomaRecruitingNCT05276167Not applicable
- Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant CandidatesRecruitingNCT05276037
- DEB-TACE+HAIC vs. HAIC for Large HCCRecruitingNCT05263219Phase 3